Comparison of Milan and UCSF criteria for liver transplantation to treat hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 37

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

672

HTML

6255

Figures (1-5)

354

Tables (1-4)

333

Sum=7614

Oct 7, 2011 (publication date) through May 10, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Oct 7, 2011; 17(37): 4206-4212
Published online Oct 7, 2011. doi: 10.3748/wjg.v17.i37.4206

Table 3 Follow-up data for patients who underwent orthotopic liver transplantation for hepatocellular carcinoma n (%)

UCSF: University of California San Francisco; HCC: Hepatocellular carcinoma.

Citation: Unek T, Karademir S, Arslan NC, Egeli T, Atasoy G, Sagol O, Obuz F, Akarsu M, Astarcioglu I. Comparison of Milan and UCSF criteria for liver transplantation to treat hepatocellular carcinoma. World J Gastroenterol 2011; 17(37): 4206-4212
URL: https://www.wjgnet.com/1007-9327/full/v17/i37/4206.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i37.4206